Industry News
Protein That Functions In Normal Breast May Also Contribute To Breast Cancer Metastasis
Feb 18, 2012
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade tumors and therefore associated with features of a good prognosis, it has a more sinister role in breast cancer invasion and metastasis... Read More
North Carolina-Based Genetic Resources Fuel Big Scientific Progress
Feb 18, 2012
A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross- a "library" of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discov... Read More
Statement On Critical Methotrexate Drug Shortage By American Society Of Hematology
Feb 18, 2012
As the world's largest professional society concerned with the causes and treatment of blood disorders, many of ASH's more than 16,000 members are on the front lines of dealing with the country's severe shortage of methotrexate, a drug critical in the treatment of children with acute lymphocytic leukemia (ALL)... Read More
New Drug Target For Lung Cancer Discovered By Salk Researchers
Feb 18, 2012
Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists at the Salk Institute for Biological Studies... Read More
Blood Cancer Patients To Benefit From Stem Cell Research Breakthrough
Feb 17, 2012
A landmark study published Online First in The Lancet Oncology , describes the discovery of a unique matching mechanism that affects the outcome of blood stem cell transplants and helps improving survival rates for sufferers from leukemia and other blood cancers... Read More
Blood Cancer Patients To Benefit From Stem Cell Research Breakthrough
Feb 17, 2012
A landmark study published Online First in The Lancet Oncology , describes the discovery of a unique matching mechanism that affects the outcome of blood stem cell transplants and helps improving survival rates for sufferers from leukemia and other blood cancers... Read More
Repeat Prostate Biopsies - PROGENSA® PCA3 Assay Helps Determine, Approved By FDA
Feb 17, 2012
On Wednesday, the US Food and Drug Administration (FDA) approved Gen-Probe's PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine whether men with a previous negative biopsy need a repeat biopsy... Read More
Botanical Formula Effective In Treating Prostate Cancer
Feb 17, 2012
A study published online in The International Journal of Oncology reports findings from a team of scientists at Indiana University, Methodist Research Institute, who examined a botanical formula containing botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms, and antioxidants, that kills aggressive prostate cancer tumors... Read More
Computerized System Matches Patient To Clinical Trial More Efficiently
Feb 17, 2012
The Moffit Cancer Center has received a new patent for a computerized system that efficiently matches the right patient with the right clinical trial... Read More
Botanical Formula Effective In Treating Prostate Cancer
Feb 17, 2012
A study published online in The International Journal of Oncology reports findings from a team of scientists at Indiana University, Methodist Research Institute, who examined a botanical formula containing botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms, and antioxidants, that kills aggressive prostate cancer tumors... Read More
Previous Page Next Page